THE MODE OF ACTION OF QUINOLONES - THE PARADOX IN ACTIVITY OF LOW AND HIGH-CONCENTRATIONS AND ACTIVITY IN THE ANAEROBIC ENVIRONMENT

被引:76
作者
LEWIN, CS [1 ]
MORRISSEY, I [1 ]
SMITH, JT [1 ]
机构
[1] UNIV LONDON, SCH PHARM, MICROBIOL SECT, LONDON WC1N 1AX, ENGLAND
关键词
D O I
10.1007/BF01966996
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
All 4-quinolones that have been examined display rapid bactericidal activity which is biphasic. At concentrations above the MIC, the lethality of the drugs increases until a concentration known as the optimum bactericidal concentration (OBC) beyond which the bactericidal activity then declines. The biphasic response appears to be due to the inhibition of RNA synthesis at concentrations above the OBC, as RNA synthesis is required for the full bactericidal activity of the 4-quinolones. However, differences in the biphasic response are observed as some fluoroquinolones are still able to kill bacteria in the absence of bacterial protein or RNA synthesis, thus reducing the inhibition of bactericidal activity at concentrations above the OBC. It has been proposed that this ability to kill bacteria in the absence of protein or RNA synthesis is due to the possession of an additional bactericidal mechanism by these fluoroquinolones. Oxygen also appears to be essential for the lethality of the clinically available 4-quinolones although it is not required for the drugs to inhibit bacterial multiplication. Therefore these drugs are not bactericidal under anaerobic conditions.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 70 条
[51]   BACTERIAL MUTAGENICITY AND THE 4-QUINOLONES [J].
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (06) :771-773
[52]   MECHANISMS OF RESISTANCE TO QUINOLONES AND CLINICAL PERSPECTIVES [J].
PIDDOCK, LJV ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (04) :475-480
[53]   INVITRO STUDIES OF S-25930 AND S-25932, 2 NEW 4-QUINOLONES [J].
PIDDOCK, LJV ;
ANDREWS, JM ;
DIVER, JM ;
WISE, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (03) :303-310
[54]   EFFECT OF FERROUS SULFATE AND MULTIVITAMINS WITH ZINC ON ABSORPTION OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].
POLK, RE ;
HEALY, DP ;
SAHAI, J ;
DRWAL, L ;
RACHT, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) :1841-1844
[55]  
RATCLIFFE N T, 1985, Journal of Pharmacy and Pharmacology, V37, p92P
[56]  
RATCLIFFE N T, 1983, Journal of Pharmacy and Pharmacology, V35, p61P
[57]  
RATCLIFFE NT, 1985, CHEMIOTERAPIA S2, V4, P385
[58]   INVITRO AND INVIVO ACTIVITIES OF A NEW QUINOLONE, WIN-57273, POSSESSING POTENT ACTIVITY AGAINST GRAM-POSITIVE BACTERIA [J].
SEDLOCK, DM ;
DOBSON, RA ;
DEUEL, DM ;
LESHER, GY ;
RAKE, JB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :568-575
[59]   RANDOMIZED EVALUATION OF CEFTAZIDIME OR TICARCILLIN AND TOBRAMYCIN FOR THE TREATMENT OF OSTEOMYELITIS CAUSED BY GRAM-NEGATIVE BACILLI [J].
SHEFTEL, TG ;
MADER, JT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :112-115
[60]   MECHANISM OF INHIBITION OF DNA GYRASE BY ANALOGS OF NALIDIXIC-ACID - THE TARGET OF THE DRUGS IS DNA [J].
SHEN, LL ;
PERNET, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (02) :307-311